Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Thomas Haegin who wrote (1648)	5/29/1998 9:05:00 AM
From: CPM	Read Replies (1) \| Respond to of 2068

Firstly, Norman's buying of the shares was what he promised as his infusion of money after the financing deal was struck. IMO, he bought in at a great price, and in the next few years, yes the stock might be back up close to previous levels before it fell. But, I don't see it as a sign that this stock will jump. The only way this stock will jump is if some company such as United Health, or Aetna buys Oxford. Again, just my thoughts. Have a great weekend, CPM

To: Thomas Haegin who wrote (1648)	6/10/1998 10:54:00 AM
From: Thomas Haegin	Read Replies (1) \| Respond to of 2068

Insider tracking as per Yahoo! A nifty new feature from Yahoo! biz.yahoo.com Notice the many option exercised also. They got a v.g. price, but some believing is still necessay, even at $4. Also note that Payson bought for $20M. I thought he was supposed to buy only for $10M. Please correct me anyone. If not, that's another positive sign, I'd say. regards, Thomas

To: Thomas Haegin who wrote (1648)	6/10/1998 11:02:00 AM
From: Thomas Haegin	Read Replies (1) \| Respond to of 2068

Partial Repost: Oxford says completes expected $710 mill financing Dug it up again from my HD-drive. Seems like Payson invested more than was expected.... Thomas -------------- Reuters Story - May 13, 1998 16:44 ÿÿÿ NORWALK, Conn., May 13 (Reuters) - Oxford Health Plans Inc said Wednesday it had successfully completed the $710 million equity and debt financing the company had proposed in February, adding it had officially named Norman Payson as its chief executive. ÿÿÿ Payson was selected for the job in February in a major shakeup of the health maintenance organization and had been acting unofficially in that capacity since then. ÿÿÿ The company said it had completed the sale of $350 million in Oxford preferred shares and warrants to affiliates of investment firm Texas Pacific Group and others. ÿÿÿ In separate transactions, it said it had also completed private placement of $200 million of seven-year unsecured senior notes and had borrowed $150 million under a five-year senior secured term loan. ÿÿÿ In addition, the company said Payson -- former chief executive of Healthsource Inc -- made a $10 million investment in Oxford's common shares, bringing the company's total new capital to $710 million. ÿÿÿ Oxford said Payson had also been elected to its board of directors along with David Bonderman and James G. Coulter, founding partners of Texas Pacific Group; and Jonathan Coslet, a partner of Texas Pacific Group. A final nominee of Texas Pacific Group will be named later, the company added....